With more investment in women’s health than ever before, there are newer and more exciting opportunities for innovation, but it’s important to consider what types of investment will achieve the best ROI. Join this discussion to hear from a panel of experts about the investment strategies they’ve adopted, understand the innovation that’s exciting to them, and consider the key factors for long term financial success.

According to the American Heart Association, nearly 75% of coronary heart disease cases in women can be prevented. Identifying sex-specific
risk factors through personalized risk assessments is an important step in creating precise treatment options to improve heart health. Join this panel discussion to hear from those leading the way in reducing the number one death of women in the US.

This presentation will cover VitalDose’s role in patient centric delivery within Women’s Health, exploring how using the sustained release of single or multiple drugs can relieve patient burden in chronic diseases and provide a benefit to the formulation of small molecule API to larger molecule or complex therapeutics.

Improving the benchmark for measuring disease modification and reducing the use of symptomology is imperative for addressing underserved areas in women’s health such as ovarian cancer and endometriosis. This panel discussion will deep dive into the importance of prioritizing research through a sex & gender lens to identify new molecules, exploring the challenges and opportunities in investing in early-stage research, partnering with research institutions, and considering what more can be done.